Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity. — Stella

Home/Repeated IVF Failure/

View on ClinicalTrials.gov

Recruiting

Back to Repeated IVF Failure trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Japan

IVF Namba Clinic, Sankaky Medical Corporation, Osaka, Osaka

Key details

Sponsor

Sunkaky Medical Cooperation

Collaborators

Abinopharm, Inc, Aba Chemicals Co Ltd

Enrollment target

~60 participants

Started

August 2024

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

32 Years – 42 Years

Sex

Female only

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.